[Retracted] Effects of Gemcitabine and Oxaliplatin Combined with Apatinib on Immune Function and Levels of SIL-2R and sicAM-1 in Patients with Gallbladder Cancer

Table 1

Comparison of immune index levels.

Group	Period	Observation group	Control group
		(n = 58)	(n = 58)
CD3+(%)	Before	47.92 9.56	47.85 9.58
	After	54.83 11.97	62.97 12.74
CD4+(%)	Before	35.86 6.98	35.87 6.84
	After	40.15 7.57	48.97 8.12
CD8+(%)	Before	25.12 6.42	25.13 6.48
	After	22.97 5.14	16.89 4.23
CD4+/CD8+	Before	1.33 0.29	1.35 0.26
	After	1.58 0.34	1.89 0.52
NK(%)	Before	16.89 4.16	17.23 4.39
	After	32.76 6.98	37.89 7.42